HDFC Pharma and Healthcare Fund - Regular Plan - Growth - NAV, Mutual Fund Performance & Portfolio

HDFC Pharma and Healthcare Fund - Regular Plan - Growth

Equity Sector Funds Very High Risk Fund Manager: Nikhil Mathur

📓 Notes

24.58%

1Y Return

0.97% 1D

Overview Returns Historical Holdings Peer Comparison Fund Managers AMC FAQ

Latest NAV

₹21.22

Fund Size

₹3,311 Cr

Turnover Ratio

35.64

Lock-in Period

Nil

Inception Date

04 Oct 2023

Return Since Inception

28.56%

Fund Type

Open ended scheme

Min. Lumpsum / SIP

₹100 / ₹100

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Looking to Grow Your Wealth with Mutual Funds?

Expert-managed portfolios tailored to your financial goals and risk appetite.

NAV Performance

Historical Net Asset Value

24.58% 1Y Return

≤ 1 year — Absolute; > 1 year — CAGR

Return Calculator

Estimation based on past performance

Monthly Investment

₹

Over The Past

Invested Amount

Est. Returns

After 0 Years your investment will be:
₹ 0 (0%)

Lumpsum Investment

₹

Over The Past

Invested Amount

Est. Returns

After 0 Years your investment will be:
₹ 0 (0%)

Returns and Rankings

Benchmark: BSE Health Care - TRI

Sector Funds	1M	3M	6M	9M	1Y	2Y	3Y	4Y	5Y	10Y	ALL
Fund returns	-1.96%	2.52%	25.9%	20.68%	24.58%	14.98%	28.56%	N/A	N/A	N/A	28.56%
Category returns	-2.38%	0.98%	21.27%	13.65%	15.21%	6.84%	20.17%	19.31%	13.54%	13.51%	N/A
Absolute returns	-1.96%	2.52%	25.9%	20.68%	24.58%	32.31%	112.64%	N/A	N/A	N/A	112.94%
Rank within category	4/18	5/18	2/18	2/18	2/17	1/14	1/12	N/A	N/A	N/A	N/A

≤ 1 year — Absolute; > 1 year — CAGR

Historical Data

Benchmark: BSE Health Care - TRI

Sector Funds	2023	2024	2025	2026
Yearly returns	N/A	50.33%	1.22%	23.15%
Q1 returns	N/A	8.5%	-6.47%	-1.46%
Q2 returns	N/A	6.75%	5.72%	20.16%
Q3 returns	N/A	23.01%	-0.42%	3.82%
Q4 returns	N/A	5.51%	2.8%	0.18%

Expense Ratio, Exit Load & Tax

Expense Ratio: 2.11% (Inclusive of GST)

Exit Load

1% on or before 30D, Nil after 30D

Advanced Ratios

Alpha	1.81832
Beta	0.5727
Sharpe Ratio	0.479883
Sortino Ratio	1.05347

Risk Metrics

R-Squared	0.2634
Tracking Error	3.7584
Downside Risk	14.2341
Std. Deviation (Annualised)	13.8563

Peer Comparison

Sector Funds	1M	3M	6M	9M	1Y	3Y	5Y	10Y	ALL	Fund Size (Cr)	Exp. Ratio	Sharpe	Risk
HDFC Pharma and Healthcare Fund - Regular Plan - Growth Current	-1.96%	2.52%	25.9%	20.68%	24.58%	28.56%	N/A	N/A	28.56%	3,310.64	2.11	0.48	Very High
SBI Healthcare Opportunities Fund - Regular Plan - IDCW	-2.94%	0.94%	22.81%	17.57%	17.88%	21.83%	16.69%	13.33%	16.57%	5,796.42	2.00	0.36	Very High
UTI Healthcare Fund - Regular Plan - IDCW	-3.22%	0.56%	22.69%	15.06%	14.67%	21.82%	14.25%	13.44%	14.94%	1,429.84	2.22	0.34	Very High
ICICI Prudential Healthcare Fund - Growth	-2.36%	-3.03%	15.18%	4.94%	6.63%	20.73%	14.84%	N/A	19.12%	6,995.62	2.08	0.31	Very High
Mirae Asset Healthcare Fund - Regular Plan - Growth	-1.37%	1.47%	20.72%	15.43%	17.4%	20.65%	13.73%	N/A	19.98%	3,555.18	2.04	0.31	Very High
LIC MF Healthcare Fund - Regular Plan - Growth	-3.5%	1.21%	21.34%	11.16%	11.73%	19.96%	10.82%	N/A	16.95%	103.11	2.67	0.30	Very High
DSP Healthcare Fund - Regular Plan - Growth	-2.14%	1.63%	24.18%	11.37%	14.62%	19.62%	14.09%	N/A	21%	3,835.28	2.05	0.30	Very High
Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth	-2.75%	-0.03%	18.69%	12.76%	14.62%	18.88%	12.49%	N/A	19.07%	1,102.73	2.29	0.30	Very High
Quant Healthcare Fund - Regular Plan - Growth	-2.13%	2.74%	21.8%	16.66%	16.64%	18.72%	N/A	N/A	19.66%	428.30	3.13	0.24	Very High
ITI Pharma & Healthcare Fund - Regular Plan - Growth	-2.2%	0.08%	19.58%	10.81%	9.58%	17.23%	N/A	N/A	12.25%	276.23	2.63	0.23	Very High

Holdings (41)

Instrument Type

Domestic Equities

98.42%

Cash & Cash Equivalents and Net Assets

1.58%

Sector

Pharmaceuticals & Biotechnology

72.12%

Healthcare Services

24.15%

Others

1.58%

Healthcare Equipment & Supplies

2.15%

Name	Sector	Instrument	Assets %
Divi's Laboratories Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	9.54%
Sun Pharmaceutical Industries Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	8.94%
Torrent Pharmaceuticals Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	4.08%
Max Healthcare Institute Ltd.	Healthcare Services	Domestic Equities	4.06%
Lupin Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	4.04%
Cipla Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	3.94%
Aster DM Quality Care Ltd.	Healthcare Services	Domestic Equities	3.84%
Neuland Laboratories Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	3.70%
Anthem Biosciences Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	3.48%
Acutaas Chemicals Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	3.24%
Ipca Laboratories Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	3.23%
Shilpa Medicare Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	3.10%
Alkem Laboratories Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	3.06%
Global Health Ltd.	Healthcare Services	Domestic Equities	2.85%
Rubicon Research Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	2.82%
Fortis Healthcare Ltd.	Healthcare Services	Domestic Equities	2.37%
Glenmark Pharmaceuticals Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	2.34%
Krishna Institute of Medical Sciences Ltd	Healthcare Services	Domestic Equities	2.25%
Vijaya Diagnostic Centre Ltd.	Healthcare Services	Domestic Equities	2.24%
Jupiter Life Line Hospitals Ltd.	Healthcare Services	Domestic Equities	1.94%
Zydus Lifesciences Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.93%
Metropolis Healthcare Ltd.	Healthcare Services	Domestic Equities	1.90%
Dr. Reddy's Laboratories Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.90%
TREPS - Tri-party Repo		Cash & Cash Equivalents and Net Assets	1.83%
Molbio Diagnostics Ltd.	Healthcare Equipment & Supplies	Domestic Equities	1.77%
Biocon Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.73%
Wockhardt Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.61%
Sai Life Sciences Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.60%
Apollo Hospitals Enterprise Ltd.	Healthcare Services	Domestic Equities	1.39%
Thyrocare Technologies Ltd.	Healthcare Services	Domestic Equities	1.31%
Symbiotec Pharmalab Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.21%
Ajanta Pharma Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.18%
Gland Pharma Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.09%
CORONA Remedies Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.07%
Eris Lifesciences Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	1.06%
Jubilant Pharmova Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	0.85%
Bajaj Healthcare Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	0.57%
Novartis India Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	0.47%
Laxmi Dental Ltd.	Healthcare Equipment & Supplies	Domestic Equities	0.38%
Cohance Lifesciences Ltd.	Pharmaceuticals & Biotechnology	Domestic Equities	0.34%
Net Current Assets		Cash & Cash Equivalents and Net Assets	-0.25%
Total			100.00%

FUND MANAGERS

Managed By Experts

Mr. Nikhil Mathur

Over 7 years of experience in equity research and 2 years in financial advisory.

Age

35 Yrs

Experience

7 Years

Reported

14 Sep 2023

PGDM - IMT, B.E. (Civil), CFA (USA)

AMC

Asset Management Companies

360 ONE Mutual Fund

Abakkus Mutual Fund

Aditya Birla Sun Life Mutual Fund

Angel One Mutual Fund

Bajaj Finserv Mutual Fund

Bandhan Mutual Fund

Bank of India Mutual Fund

Baroda BNP Paribas Mutual Fund

Canara Robeco Mutual Fund

Capitalmind Mutual Fund

Edelweiss - Altiva SIF

Edelweiss Mutual Fund

Franklin Templeton Mutual Fund

ICICI Prudential Mutual Fund

IL&FS Mutual Fund (IDF)

Jio BlackRock Mutual Fund

JM Financial Mutual Fund

Kotak Mahindra Mutual Fund

LIC Mutual Fund

Mahindra Manulife Mutual Fund

Mirae Asset Mutual Fund

Monarch Mutual Fund

Motilal Oswal Mutual Fund

Navi Mutual Fund

Nippon India Mutual Fund

NJ Mutual Fund

Old Bridge Mutual Fund

PGIM India Mutual Fund

The Wealth Company Mutual Fund

WhiteOak Capital Mutual Fund

WSIF

Zerodha Mutual Fund

FAQ

All You Need To Know About Mutual Funds

It is an Open ended scheme that primarily invests in Sector Funds.

To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

The scheme benchmark is the BSE Health Care - TRI.

It is classified as Very High Risk.

1-year: 24.58% | 3-year: 28.56% | 5-year: N/A (scheme is younger than 5 years)

Top holdings include: Divi's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Max Healthcare Institute Ltd., Lupin Ltd.

The NAV is around ₹21.22.

The fund's AUM is approximately ₹3,311 Cr.

The expense ratio for the Regular Plan is 2.11%.

1% on or before 30D, Nil after 30D.

Minimum SIP starts at ₹100.

The minimum lump sum investment is ₹100.

You can start a SIP through the Sharescart platform. Enter KYC details, choose the Regular Growth option, set SIP amount and frequency, and submit.

The fund manager: Nikhil Mathur

This fund is suitable for investors with a Very High risk tolerance.

📈